{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T09:22:23Z","timestamp":1788340943102,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["23AARF-1027342"],"award-info":[{"award-number":["23AARF-1027342"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["U19 AG069701"],"award-info":[{"award-number":["U19 AG069701"]}]},{"name":"NIH","award":["R01AG 55549"],"award-info":[{"award-number":["R01AG 55549"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"DOI":"10.1038\/s44386-026-00072-3","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:56:13Z","timestamp":1788339373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Discovery and preclinical validation of a translationally optimized mitochondrial complex I modulator for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"3","author":[{"given":"Sergey","family":"Trushin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Kim Oanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ostroot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarred J.","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Galkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Nambara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-2860","authenticated-orcid":false,"given":"Eugenia","family":"Trushina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"72_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41572-021-00269-y","volume":"7","author":"DS Knopman","year":"2021","unstructured":"Knopman, D. S. et al. Alzheimer disease. Nat. Rev. Dis. Prim. 7, 33 https:\/\/doi.org\/10.1038\/s41572-021-00269-y (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"72_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/procel\/pwae026","volume":"16","author":"Q Zheng","year":"2025","unstructured":"Zheng, Q. & Wang, X. Alzheimer\u2019s disease: insights into pathology, molecular mechanisms, and therapy. Protein Cell 16, 83\u2013120 https:\/\/doi.org\/10.1093\/procel\/pwae026 (2025).","journal-title":"Protein Cell"},{"key":"72_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2026.1772036","volume":"17","author":"X Xiao","year":"2026","unstructured":"Xiao, X., Yan, X., Liang, C. & Yang, Y. Metabolic dysfunction and mitochondrial failure in Alzheimer\u2019s disease: integrating pathophysiology, clinical evidence and emerging interventions. Front Neurol. 17, 1772036 https:\/\/doi.org\/10.3389\/fneur.2026.1772036 (2026).","journal-title":"Front Neurol."},{"key":"72_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/alz.12683","volume":"19","author":"T Ashleigh","year":"2023","unstructured":"Ashleigh, T., Swerdlow, R. H. & Beal, M. F. The role of mitochondrial dysfunction in Alzheimer\u2019s disease pathogenesis. Alzheimers Dement 19, 333\u2013342 https:\/\/doi.org\/10.1002\/alz.12683 (2023).","journal-title":"Alzheimers Dement"},{"key":"72_CR5","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","volume":"15","author":"W Wang","year":"2020","unstructured":"Wang, W., Zhao, F., Ma, X., Perry, G. & Zhu, X. Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol. Neurodegener. 15, 30 https:\/\/doi.org\/10.1186\/s13024-020-00376-6 (2020).","journal-title":"Mol. Neurodegener."},{"key":"72_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39828-5","volume":"9","author":"L Caberlotto","year":"2019","unstructured":"Caberlotto, L. et al. Cross-disease analysis of Alzheimer\u2019s disease and type-2 Diabetes highlights the role of autophagy in the pathophysiology of two highly comorbid diseases. Sci. Rep. 9, 3965 https:\/\/doi.org\/10.1038\/s41598-019-39828-5 (2019).","journal-title":"Sci. Rep."},{"key":"72_CR7","doi-asserted-by":"publisher","unstructured":"Jurcau, M. C. et al. The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants 11, 2167 https:\/\/doi.org\/10.3390\/antiox11112167 (2022).","DOI":"10.3390\/antiox11112167"},{"key":"72_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-90925-0","volume":"15","author":"N Keller","year":"2025","unstructured":"Keller, N., Christensen, T. A., Wanberg, E. J., Salisbury, J. L. & Trushina, E. Neuroprotective mitochondria targeted small molecule restores synapses and the distribution of synaptic mitochondria in the hippocampus of APP\/PS1 mice. Sci. Rep. 15, 6528 https:\/\/doi.org\/10.1038\/s41598-025-90925-0 (2025).","journal-title":"Sci. Rep."},{"key":"72_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/alzrt74","volume":"3","author":"A Eckert","year":"2011","unstructured":"Eckert, A., Schmitt, K. & Gotz, J. Mitochondrial dysfunction\u2014the beginning of the end in Alzheimer\u2019s disease? Separate and synergistic modes of tau and amyloid-beta toxicity. Alzheimers Res. Ther. 3, 15 https:\/\/doi.org\/10.1186\/alzrt74 (2011).","journal-title":"Alzheimers Res. Ther."},{"key":"72_CR10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.apsb.2021.11.003","volume":"12","author":"E Trushina","year":"2022","unstructured":"Trushina, E., Trushin, S. & Hasan, M. F. Mitochondrial complex I as a therapeutic target for Alzheimer\u2019s disease. Acta Pharm. Sin. B. 12, 483\u2013495 https:\/\/doi.org\/10.1016\/j.apsb.2021.11.003 (2022).","journal-title":"Acta Pharm. Sin. B."},{"key":"72_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-026-10474-8","author":"P Mandal","year":"2026","unstructured":"Mandal, P., Trushina, E., Arnold, M., Kaddurah-Daouk, R. & Baloni, P. Mitochondrial bioenergetic signatures differentiate asymptomatic from symptomatic Alzheimer\u2019s disease. Commun. Biol https:\/\/doi.org\/10.1038\/s42003-026-10474-8 (2026).","journal-title":"Commun. Biol"},{"key":"72_CR12","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1146\/annurev-biochem-070511-103700","volume":"82","author":"J Hirst","year":"2013","unstructured":"Hirst, J. Mitochondrial complex I. Annu. Rev. Biochem. 82, 551\u2013575 https:\/\/doi.org\/10.1146\/annurev-biochem-070511-103700 (2013).","journal-title":"Annu. Rev. Biochem."},{"key":"72_CR13","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.immuni.2025.07.012","volume":"58","author":"SE Weinberg","year":"2025","unstructured":"Weinberg, S. E. & Chandel, N. S. Mitochondria reactive oxygen species signaling-dependent immune responses in macrophages and T cells. Immunity 58, 1904\u20131921 https:\/\/doi.org\/10.1016\/j.immuni.2025.07.012 (2025).","journal-title":"Immunity"},{"key":"72_CR14","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1172\/JCI64264","volume":"123","author":"AF Santidrian","year":"2013","unstructured":"Santidrian, A. F. et al. Mitochondrial complex I activity and NAD+\/NADH balance regulate breast cancer progression. J. Clin. Invest 123, 1068\u20131081 https:\/\/doi.org\/10.1172\/JCI64264 (2013).","journal-title":"J. Clin. Invest"},{"key":"72_CR15","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.molcel.2026.01.008","volume":"86","author":"A Meichsner","year":"2026","unstructured":"Meichsner, A., Bader, V. & Winklhofer, K. F. Mitochondria as sources and targets of cellular signaling. Mol. Cell 86, 503\u2013521 https:\/\/doi.org\/10.1016\/j.molcel.2026.01.008 (2026).","journal-title":"Mol. Cell"},{"key":"72_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.cmet.2015.05.013","volume":"22","author":"NS Chandel","year":"2015","unstructured":"Chandel, N. S. Evolution of mitochondria as signaling organelles. Cell Metab. 22, 204\u2013206 https:\/\/doi.org\/10.1016\/j.cmet.2015.05.013 (2015).","journal-title":"Cell Metab."},{"key":"72_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.mad.2016.12.002","volume":"165","author":"G Rose","year":"2017","unstructured":"Rose, G., Santoro, A. & Salvioli, S. Mitochondria and mitochondria-induced signalling molecules as longevity determinants. Mech. Ageing Dev. 165, 115\u2013128 https:\/\/doi.org\/10.1016\/j.mad.2016.12.002 (2017).","journal-title":"Mech. Ageing Dev."},{"key":"72_CR18","doi-asserted-by":"publisher","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","volume":"23","author":"TB Sherer","year":"2003","unstructured":"Sherer, T. B. et al. Mechanism of toxicity in rotenone models of Parkinson\u2019s disease. J. Neurosci. 23, 10756\u201310764 https:\/\/doi.org\/10.1523\/JNEUROSCI.23-34-10756.2003 (2003).","journal-title":"J. Neurosci."},{"key":"72_CR19","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41580-022-00506-6","volume":"23","author":"CF Bennett","year":"2022","unstructured":"Bennett, C. F., Latorre-Muro, P. & Puigserver, P. Mechanisms of mitochondrial respiratory adaptation. Nat. Rev. Mol. Cell Biol. 23, 817\u2013835 https:\/\/doi.org\/10.1038\/s41580-022-00506-6 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1146\/annurev-physiol-060721-095517","volume":"84","author":"HR Spaulding","year":"2022","unstructured":"Spaulding, H. R. & Yan, Z. AMPK and the adaptation to exercise. Annu. Rev. Physiol. 84, 209\u2013227 https:\/\/doi.org\/10.1146\/annurev-physiol-060721-095517 (2022).","journal-title":"Annu. Rev. Physiol."},{"key":"72_CR21","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","volume":"24","author":"GR Steinberg","year":"2023","unstructured":"Steinberg, G. R. & Hardie, D. G. New insights into activation and function of the AMPK. Nat. Rev. Mol. Cell Biol. 24, 255\u2013272 https:\/\/doi.org\/10.1038\/s41580-022-00547-x (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig, S. & Shaw, R. J. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 19, 121\u2013135 https:\/\/doi.org\/10.1038\/nrm.2017.95 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"72_CR23","doi-asserted-by":"publisher","first-page":"12017","DOI":"10.1073\/pnas.0705070104","volume":"104","author":"S Jager","year":"2007","unstructured":"Jager, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alpha. Proc. Natl. Acad. Sci. USA 104, 12017\u201312022 https:\/\/doi.org\/10.1073\/pnas.0705070104 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.celrep.2017.09.026","volume":"21","author":"RC Rabinovitch","year":"2017","unstructured":"Rabinovitch, R. C. et al. AMPK maintains cellular metabolic homeostasis through regulation of mitochondrial reactive oxygen species. Cell Rep. 21, 1\u20139 https:\/\/doi.org\/10.1016\/j.celrep.2017.09.026 (2017).","journal-title":"Cell Rep."},{"key":"72_CR25","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00109-011-0748-0","volume":"89","author":"A Salminen","year":"2011","unstructured":"Salminen, A., Hyttinen, J. M. & Kaarniranta, K. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J. Mol. Med. 89, 667\u2013676 https:\/\/doi.org\/10.1007\/s00109-011-0748-0 (2011).","journal-title":"J. Mol. Med."},{"key":"72_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/JAD-201015","volume":"79","author":"A Stojakovic","year":"2021","unstructured":"Stojakovic, A. et al. Partial inhibition of mitochondrial complex i reduces tau pathology and improves energy homeostasis and synaptic function in 3xTg-AD mice. J. Alzheimers Dis. 79, 335\u2013353 https:\/\/doi.org\/10.3233\/JAD-201015 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"72_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s42003-020-01584-y","volume":"4","author":"A Stojakovic","year":"2021","unstructured":"Stojakovic, A. et al. Partial inhibition of mitochondrial complex I ameliorates Alzheimer\u2019s disease pathology and cognition in APP\/PS1 female mice. Commun. Biol. 4, 61 https:\/\/doi.org\/10.1038\/s42003-020-01584-y (2021).","journal-title":"Commun. Biol."},{"key":"72_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105924","volume":"120","author":"S Trushin","year":"2025","unstructured":"Trushin, S. et al. Therapeutic assessment of a novel mitochondrial complex I inhibitor in in vitro and in vivo models of Alzheimer\u2019s disease. EBioMedicine 120, 105924 https:\/\/doi.org\/10.1016\/j.ebiom.2025.105924 (2025).","journal-title":"EBioMedicine"},{"key":"72_CR29","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ebiom.2015.03.009","volume":"2","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer\u2019s Disease. EBioMedicine 2, 294\u2013305 https:\/\/doi.org\/10.1016\/j.ebiom.2015.03.009 (2015).","journal-title":"EBioMedicine"},{"key":"72_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mito.2021.02.005","volume":"58","author":"H Gao","year":"2021","unstructured":"Gao, H. et al. A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor. Mitochondrion 58, 83\u201394 https:\/\/doi.org\/10.1016\/j.mito.2021.02.005 (2021).","journal-title":"Mitochondrion"},{"key":"72_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70519","volume":"21","author":"H Gao","year":"2025","unstructured":"Gao, H. et al. Mitochondrial complex I deficiency induces Alzheimer\u2019s disease-like signatures that are reversible by targeted therapy. Alzheimers Dement 21, e70519 https:\/\/doi.org\/10.1002\/alz.70519 (2025).","journal-title":"Alzheimers Dement"},{"key":"72_CR32","doi-asserted-by":"publisher","unstructured":"Panes, J. et al. Partial inhibition of complex I restores mitochondrial morphology and mitochondria-ER communication in hippocampus of APP\/PS1 mice. Cells 12, 1111 https:\/\/doi.org\/10.3390\/cells12081111 (2023).","DOI":"10.3390\/cells12081111"},{"key":"72_CR33","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3233\/JAD-161175","volume":"58","author":"I Maezawa","year":"2017","unstructured":"Maezawa, I. et al. The anti-amyloid-beta and neuroprotective properties of a novel tricyclic pyrone molecule. J. Alzheimers Dis. 58, 559\u2013574 https:\/\/doi.org\/10.3233\/JAD-161175 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"72_CR34","doi-asserted-by":"publisher","DOI":"10.64898\/2026.06.14.732179","author":"E Gabal","year":"2026","unstructured":"Gabal, E. et al. Mitochondrial complex I modulator restores network resilience in advanced Alzheimer\u2019s disease through metabolic reprogramming. bioRxiv https:\/\/doi.org\/10.64898\/2026.06.14.732179 (2026).","journal-title":"bioRxiv"},{"key":"72_CR35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.14283\/jpad.2023.108","volume":"10","author":"E Trushina","year":"2023","unstructured":"Trushina, E., Nguyen, T. K. O. & Trushin, S. Modulation of mitochondrial function as a therapeutic strategy for neurodegenerative diseases. J. Prev. Alzheimers Dis. 10, 675\u2013685 https:\/\/doi.org\/10.14283\/jpad.2023.108 (2023).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"72_CR36","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1471-4159.2006.03862.x","volume":"98","author":"I Maezawa","year":"2006","unstructured":"Maezawa, I. et al. A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J. Neurochem 98, 57\u201367 https:\/\/doi.org\/10.1111\/j.1471-4159.2006.03862.x (2006).","journal-title":"J. Neurochem"},{"key":"72_CR37","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","volume":"58","author":"Z Rankovic","year":"2015","unstructured":"Rankovic, Z. CNS drug design: balancing physicochemical properties for optimal brain exposure. J. Med Chem. 58, 2584\u20132608 https:\/\/doi.org\/10.1021\/jm501535r (2015).","journal-title":"J. Med Chem."},{"key":"72_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0169-328x(94)90092-2","volume":"26","author":"BL Sopher","year":"1994","unstructured":"Sopher, B. L. et al. Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Mol. Brain Res. 26, 207\u2013217 https:\/\/doi.org\/10.1016\/0169-328x(94)90092-2 (1994).","journal-title":"Mol. Brain Res."},{"key":"72_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03020-9","volume":"11","author":"L Huang","year":"2020","unstructured":"Huang, L. et al. Intracellular amyloid toxicity induces oxytosis\/ferroptosis regulated cell death. Cell Death Dis. 11, 828 https:\/\/doi.org\/10.1038\/s41419-020-03020-9 (2020).","journal-title":"Cell Death Dis."},{"key":"72_CR40","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/fj.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti, P., Fovez, Q., Germain, N., Khamari, R. & Kluza, J. Mitochondrial spare respiratory capacity: Mechanisms, regulation, and significance in non-transformed and cancer cells. FASEB J. 34, 13106\u201313124 https:\/\/doi.org\/10.1096\/fj.202000767R (2020).","journal-title":"FASEB J."},{"key":"72_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19264-0","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao, J. et al. APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer\u2019s disease patient iPSC-derived cerebral organoids. Nat. Commun. 11, 5540 https:\/\/doi.org\/10.1038\/s41467-020-19264-0 (2020).","journal-title":"Nat. Commun."},{"key":"72_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjpad.2025.100465","volume":"13","author":"N Fandos","year":"2026","unstructured":"Fandos, N. et al. Plasma Abeta42\/Abeta40 determined by mass spectrometry is associated with longitudinal changes in amyloid accumulation, brain atrophy, and conversion to mild cognitive impairment due to Alzheimer\u2019s disease in individuals with subjective cognitive decline: 5-year follow-up of the FACEHBI cohort. J. Prev. Alzheimers Dis. 13, 100465 https:\/\/doi.org\/10.1016\/j.tjpad.2025.100465 (2026).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"72_CR43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2414176121","volume":"121","author":"P Chakraborty","year":"2024","unstructured":"Chakraborty, P. et al. GSK3beta phosphorylation catalyzes the aggregation of tau into Alzheimer\u2019s disease-like filaments. Proc. Natl. Acad. Sci. USA 121, e2414176121 https:\/\/doi.org\/10.1073\/pnas.2414176121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"72_CR44","doi-asserted-by":"publisher","unstructured":"Sayas, C. L. & Avila, J. GSK-3 and tau: a key duet in Alzheimer\u2019s disease. Cells 10 https:\/\/doi.org\/10.3390\/cells10040721 (2021)","DOI":"10.3390\/cells10040721"},{"key":"72_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.70098","volume":"11","author":"JL Cummings","year":"2025","unstructured":"Cummings, J. L. et al. Alzheimer\u2019s disease drug development pipeline: 2025. Alzheimers Dement 11, e70098 https:\/\/doi.org\/10.1002\/trc2.70098 (2025).","journal-title":"Alzheimers Dement"},{"key":"72_CR46","doi-asserted-by":"publisher","unstructured":"Papaliagkas, V. Anti-amyloid therapies for Alzheimer\u2019s disease: progress, pitfalls, and the path ahead. Int. J. Mol. Sci. 26, 9529 https:\/\/doi.org\/10.3390\/ijms26199529 (2025).","DOI":"10.3390\/ijms26199529"},{"key":"72_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101503","volume":"72","author":"T Song","year":"2021","unstructured":"Song, T. et al. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer\u2019s disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies. Ageing Res. Rev. 72, 101503 https:\/\/doi.org\/10.1016\/j.arr.2021.101503 (2021).","journal-title":"Ageing Res. Rev."},{"key":"72_CR48","doi-asserted-by":"publisher","first-page":"11357","DOI":"10.1007\/s00210-025-04014-0","volume":"398","author":"AS Wadan","year":"2025","unstructured":"Wadan, A. S. et al. Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature. Naunyn Schmiedebergs Arch. Pharm. 398, 11357\u201311386 https:\/\/doi.org\/10.1007\/s00210-025-04014-0 (2025).","journal-title":"Naunyn Schmiedebergs Arch. Pharm."},{"key":"72_CR49","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina, J. R. et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat. Med. 24, 1036\u20131046 https:\/\/doi.org\/10.1038\/s41591-018-0052-4 (2018).","journal-title":"Nat. Med."},{"key":"72_CR50","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/1878-0261.13583","volume":"18","author":"M Pujalte-Martin","year":"2024","unstructured":"Pujalte-Martin, M. et al. Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS-010759. Mol. Oncol. 18, 1719\u20131738 https:\/\/doi.org\/10.1002\/1878-0261.13583 (2024).","journal-title":"Mol. Oncol."},{"key":"72_CR51","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1016\/j.cell.2024.08.021","volume":"187","author":"Y Yang","year":"2024","unstructured":"Yang, Y. et al. Metformin decelerates aging clock in male monkeys. Cell 187, 6358\u20136378.e6329 https:\/\/doi.org\/10.1016\/j.cell.2024.08.021 (2024).","journal-title":"Cell"},{"key":"72_CR52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2020.04.001","volume":"32","author":"AS Kulkarni","year":"2020","unstructured":"Kulkarni, A. S., Gubbi, S. & Barzilai, N. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab. 32, 15\u201330 https:\/\/doi.org\/10.1016\/j.cmet.2020.04.001 (2020).","journal-title":"Cell Metab."},{"key":"72_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2202-10-73","volume":"10","author":"E Trushina","year":"2009","unstructured":"Trushina, E., Rana, S., McMurray, C. T. & Hua, D. H. Tricyclic pyrone compounds prevent aggregation and reverse cellular phenotypes caused by expression of mutant huntingtin protein in striatal neurons. BMC Neurosci. 10, 73 https:\/\/doi.org\/10.1186\/1471-2202-10-73 (2009).","journal-title":"BMC Neurosci."},{"key":"72_CR54","doi-asserted-by":"publisher","first-page":"23690","DOI":"10.1021\/acs.jmedchem.5c02076","volume":"68","author":"I Dzajic","year":"2025","unstructured":"Dzajic, I., Tomasic, T., Pardo, L. A., Peterlin Masic, L. & Cotman, A. E. Lipophilic cations as mitochondria-targeting moieties: recent progress and design principles for medicinal chemistry. J. Med. Chem. 68, 23690\u201323704 https:\/\/doi.org\/10.1021\/acs.jmedchem.5c02076 (2025).","journal-title":"J. Med. Chem."},{"key":"72_CR55","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/j.1471-4159.2011.07331.x","volume":"118","author":"A Salminen","year":"2011","unstructured":"Salminen, A., Kaarniranta, K., Haapasalo, A., Soininen, H. & Hiltunen, M. AMP-activated protein kinase: a potential player in Alzheimer\u2019s disease. J. Neurochem. 118, 460\u2013474 https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07331.x (2011).","journal-title":"J. Neurochem."},{"key":"72_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12017-012-8173-2","volume":"14","author":"Z Cai","year":"2012","unstructured":"Cai, Z., Yan, L. J., Li, K., Quazi, S. H. & Zhao, B. Roles of AMP-activated protein kinase in Alzheimer\u2019s disease. Neuromolecular Med. 14, 1\u201314 https:\/\/doi.org\/10.1007\/s12017-012-8173-2 (2012).","journal-title":"Neuromolecular Med."},{"key":"72_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3233\/JAD-181043","volume":"68","author":"X Wang","year":"2019","unstructured":"Wang, X., Zimmermann, H. R. & Ma, T. Therapeutic potential of AMP-activated protein kinase in Alzheimer\u2019s disease. J. Alzheimers Dis. 68, 33\u201338 https:\/\/doi.org\/10.3233\/JAD-181043 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"72_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.16","volume":"48","author":"J Kim","year":"2016","unstructured":"Kim, J., Yang, G., Kim, Y., Kim, J. & Ha, J. AMPK activators: mechanisms of action and physiological activities. Exp. Mol. Med. 48, e224 https:\/\/doi.org\/10.1038\/emm.2016.16 (2016).","journal-title":"Exp. Mol. Med."},{"key":"72_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1411-x","volume":"16","author":"HC Xiang","year":"2019","unstructured":"Xiang, H. C. et al. AMPK activation attenuates inflammatory pain through inhibiting NF-kappaB activation and IL-1beta expression. J. Neuroinflammation 16, 34 https:\/\/doi.org\/10.1186\/s12974-019-1411-x (2019).","journal-title":"J. Neuroinflammation"},{"key":"72_CR60","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.cell.2016.04.011","volume":"165","author":"Y Tian","year":"2016","unstructured":"Tian, Y. et al. Mitochondrial stress induces chromatin reorganization to promote longevity and UPR(mt). Cell 165, 1197\u20131208 https:\/\/doi.org\/10.1016\/j.cell.2016.04.011 (2016).","journal-title":"Cell"},{"key":"72_CR61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bcp.2018.01.049","volume":"153","author":"S Olivier","year":"2018","unstructured":"Olivier, S., Foretz, M. & Viollet, B. Promise and challenges for direct small molecule AMPK activators. Biochem Pharm. 153, 147\u2013158 https:\/\/doi.org\/10.1016\/j.bcp.2018.01.049 (2018).","journal-title":"Biochem Pharm."},{"key":"72_CR62","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9895121","volume":"2020","author":"BT Assefa","year":"2020","unstructured":"Assefa, B. T., Tafere, G. G., Wondafrash, D. Z. & Gidey, M. T. The bewildering effect of AMPK activators in Alzheimer\u2019s disease: review of the current evidence. Biomed. Res. Int. 2020, 9895121 https:\/\/doi.org\/10.1155\/2020\/9895121 (2020).","journal-title":"Biomed. Res. Int."},{"key":"72_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34254","volume":"10","author":"L Xia","year":"2024","unstructured":"Xia, L. et al. The role of AMPKalpha subunit in Alzheimer\u2019s disease: in-depth analysis and future prospects. Heliyon 10, e34254 https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34254 (2024).","journal-title":"Heliyon"},{"key":"72_CR64","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1172\/JCI133982","volume":"130","author":"HR Zimmermann","year":"2020","unstructured":"Zimmermann, H. R. et al. Brain-specific repression of AMPKalpha1 alleviates pathophysiology in Alzheimer\u2019s model mice. J. Clin. Invest 130, 3511\u20133527 https:\/\/doi.org\/10.1172\/JCI133982 (2020).","journal-title":"J. Clin. Invest"},{"key":"72_CR65","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1038\/s41380-020-0739-z","volume":"26","author":"W Yang","year":"2021","unstructured":"Yang, W., Zhou, X., Zimmermann, H. R. & Ma, T. Brain-specific suppression of AMPKalpha2 isoform impairs cognition and hippocampal LTP by PERK-mediated eIF2alpha phosphorylation. Mol. Psychiatry 26, 1880\u20131897 https:\/\/doi.org\/10.1038\/s41380-020-0739-z (2021).","journal-title":"Mol. Psychiatry"},{"key":"72_CR66","doi-asserted-by":"publisher","unstructured":"Drake, J. C. et al. Mitochondria-localized AMPK responds to local energetics and contributes to exercise and energetic stress-induced mitophagy. Proc. Natl. Acad. Sci. USA 118, e2025932118 https:\/\/doi.org\/10.1073\/pnas.2025932118 (2021).","DOI":"10.1073\/pnas.2025932118"},{"key":"72_CR67","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13195-025-01772-0","volume":"17","author":"A Mary","year":"2025","unstructured":"Mary, A. et al. Hampered AMPK-ULK1 cascade in Alzheimer\u2019s disease (AD) instigates mitochondria dysfunctions and AD-related alterations which are alleviated by metformin. Alzheimers Res Ther. 17, 127 https:\/\/doi.org\/10.1186\/s13195-025-01772-0 (2025).","journal-title":"Alzheimers Res Ther."},{"key":"72_CR68","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.bmcl.2008.12.060","volume":"19","author":"S Rana","year":"2009","unstructured":"Rana, S., Hong, H. S., Barrigan, L., Jin, L. W. & Hua, D. H. Syntheses of tricyclic pyrones and pyridinones and protection of Abeta-peptide induced MC65 neuronal cell death. Bioorg. Med. Chem. Lett. 19, 670\u2013674 https:\/\/doi.org\/10.1016\/j.bmcl.2008.12.060 (2009).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"72_CR69","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/j.1537-2995.2006.01033.x","volume":"46","author":"AB Dietz","year":"2006","unstructured":"Dietz, A. B. et al. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 46, 2083\u20132089 https:\/\/doi.org\/10.1111\/j.1537-2995.2006.01033.x (2006).","journal-title":"Transfusion"}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00072-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00072-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00072-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:56:15Z","timestamp":1788339375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00072-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00072-3","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"E.T. is the inventor on U.S. Patent No.12,017,992 \u201cCompounds for modulating mitochondrial function\u201d assigned to Mayo Foundation for Medical Education and Research and issued on June25, 2024. E.T., S.T., M.O. and T.K.O.N. are inventors on the patent \u201cMitochondrial Complex I inhibitors\u201d, application number 63\/746,026, filed by Mayo Foundation for Medical Education and Research on 03-02-2026. The other authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"36"}}